Development and evaluation of Chrysin-Phospholipid complex loaded solid lipid nanoparticles - storage stability and in vitro anti-cancer activity

References

• Abbasalipourkabir, R., Salehzadeh, A., and Abdullah, R., 2016. Tamoxifen-loaded solid lipid nanoparticles- induced apoptosis in breast cancer cell lines. Journal of experimental nanoscience, 11 (3), 161–174.
   Web of Science ®Google Scholar
• Alihosseini, F., et al., 2015. Freeze-drying of ampicillin solid lipid nanoparticles using mannitol as cryoprotectant. Brazilian journal of pharmaceutical sciences, 51, 797–802.
   Web of Science ®Google Scholar
• Anari, E., Akbarzadeh, A., and Zarghami, N., 2015. Chrysin-loaded PLGA-PEG nanoparticles designed for enhanced effect on the breast cancer cell line. Artificial cells, blood substitutes, and biotechnology, 44, 1–7.
   Google Scholar
• Bearer, E.L., 2003. Overview of image analysis, image importing, and image processing using freeware. Current protocols in molecular biology, Chapter 14, Unit 14.15 Supplement 63, 15.9, 1–14.
   Google Scholar
• Chaudhary, S., et al., 2014. Recent approaches of lipid-based delivery system for lymphatic targeting via oral route. Journal of drug targeting 2330, 1–12.
   Google Scholar
• Cho, J.B.C., 2015. Comparison of solid lipid nanoparticles for encapsulating paclitaxel or docetaxel. Journal of pharmaceutical investigation, 45 (7), 625–631.
   Google Scholar
• Costa, P. and Lobo, J.M.S., 2001. Modeling and comparison of dissolution profiles. European journal of pharmaceutical sciences: official journal of the european federation for pharmaceutical sciences, 13 (2), 123–133.
   PubMed Web of Science ®Google Scholar
• Dong, D., et al., 2017. Sodium oleate-based nanoemulsion enhances oral absorption of chrysin through inhibition of UGT-mediated metabolism. Molecular Pharmaceutics, 14(9), 2864–2874.
   PubMed Web of Science ®Google Scholar
• Ezhilarasi, P.N., Muthukumar, S.P., and Anandharamakrishnan, C., 2016. Solid lipid nanoparticle enhances bioavailability of hydroxycitric acid compared to a microparticle delivery system. RSC advances, 6 (59), 53784–53793.
   Web of Science ®Google Scholar
• Garg, A., et al., 2009. Solid state interaction of raloxifene HCl with different hydrophilic carriers during Co- grinding and its effect on dissolution rate. Drug development and industrial pharmacy, 35 (4), 455–470.
   PubMed Web of Science ®Google Scholar
• Garg, A., Bhalala, K., and Singh, D., 2017. In-situ single pass intestinal permeability and pharmacokinetic study of developed Lumefantrine loaded solid lipid nanoparticles. International journal of pharmaceutics, 516, 120–130.
   PubMed Web of Science ®Google Scholar
• Garg, A. and Singh, S., 2011. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers. Colloids surfaces B biointerfaces, 87 (2), 280–288.
   PubMed Web of Science ®Google Scholar
• Goel, R., Singh, B., and Mishra, A., 2011. Anticonvulsant activity of Passiflora incarnata: no role of chrysin. Journal of pharmaceutical negative results, 2 (2), 51.
   Google Scholar
• Heiati, H., Tawashi, R., and Phillips, N.C., 2008. Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving. Storage and lyophilization, 2048, 173–184.
   Google Scholar
• Hong, C., et al., 2014. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation. International journal of pharmaceutics, 477 (1-2), 251–260.
   PubMed Web of Science ®Google Scholar
• Jain, A., and Jain, S.K., 2016. In vitro release kinetic model fitting of liposomes: an insight. Chemistry and physics of lipids, 201, 28–40.
   Web of Science ®Google Scholar
• Jung, J., 2016. Emerging utilization of chrysin using nanoscale modification. Journal of Nanomaterial., doi:10.1155/2016/2894089.
   Web of Science ®Google Scholar
• Ji, P., et al., 2016. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Drug design development and therapy, 10, 911–925.
   PubMed Web of Science ®Google Scholar
• Kachadourian, R., Leitner, H.M., and Day, B.J., 2007. Selected flavonoids potentiate the toxicity of cisplatin in human lung adenocarcinoma cells: a role for glutathione depletion. International journal of oncology, 31(1), 161–168.
   PubMed Web of Science ®Google Scholar
• Kasala, E.R., Bodduluru, L.N., and Barua, C.C., 2016. Chrysin and its emerging antineoplastic effects. Cancer gene therapy, 23 (1), 43–43. doi:10.1038/cgt.2015.65
   PubMed Web of Science ®Google Scholar
• Lirdprapamongkol, K., et al., 2013. A flavonoid chrysin suppresses hypoxic survival and metastatic growth of mouse breast cancer cells. Oncology Reports, 30(5), 2357–2364. doi:10.3892/or.2013.2667.
   PubMed Web of Science ®Google Scholar
• Liu, D., et al., 2014. Formulation and characterization of hydrophilic drug diclofenac sodium-loaded solid lipid nanoparticles based on phospholipid complexes technology. Journal of liposome redearch, 2104, 17–26.
   Web of Science ®Google Scholar
• Marenduzzo, D., and Orlandini, E., 2009. Topological and entropic repulsion in biopolymers. Journal of statistical mechanics: theory and experiment, 2009 (09), L09002.
   Web of Science ®Google Scholar
• Munyendo, W.L.L., et al., 2013. Micelles of TPGS modified apigenin phospholipid complex for oral administration: preparation, In vitro and in vivo evaluation. Journal of biomedical nanotechnology, 9, 2034–2047.
   PubMed Web of Science ®Google Scholar
• Nzai, J.M., and Proctor, A., 1999. Soy lecithin phospholipid determination by Fourier transform infrared spectroscopy and the acid digest/Arseno-Molybdate method: a comparative study. Journal of the American oil chemists’ society, 76, 61–76.
   Web of Science ®Google Scholar
• Paliwal, R., et al., 2009. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine nanotechnology, biology and Medicine, 5 (2), 184–191.
   PubMed Web of Science ®Google Scholar
• Peng, Q., et al., 2010. Articles mechanisms of phospholipid complex loaded. Molecular pharmaceutics, 7, 565–575.
   PubMed Web of Science ®Google Scholar
• Qian, C., et al., 2012. Physical and chemical stability ofbeta-carotene-enriched nanoemulsions: influence of pH, ionic strength, temperature, and emulsifier type. Food chemistry, 132 (3), 1221–1229.
   PubMed Web of Science ®Google Scholar
• Rachmawati, H., et al., 2016. Destabilization mechanism of ionic surfactant on curcumin nanocrystal against electrolytes. Scientia pharmaceutica, 84 (4), 685–693.
   PubMed Web of Science ®Google Scholar
• Reddy, H.L., et al., 2005. Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton’s lymphoma tumor bearing mice. Journal of controlled release, 105 (3), 185–198.
   PubMed Web of Science ®Google Scholar
• Ryu, S., et al., 2017. Chrysin induces death of prostate cancer cells by inducing ROS and ER stress. Journal of cellular physiology, 232 (12), 3786–3797.
   PubMed Web of Science ®Google Scholar
• Sathishkumar, G., et al., 2015. Dietary flavone chrysin (5,7-dihydroxyflavone ChR) functionalized highly-stable metal nanoformulations for improved anticancer applications. RSC advances, 5 (109), 89869–89878.
   Web of Science ®Google Scholar
• Schindelin, J., et al., 2012. Fiji: an open-source platform for biological-image analysis. Nature methods, 9, 676–682.
   PubMed Web of Science ®Google Scholar
• Schwarz, C., and Mehnert, W., 1997. Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). International journal of pharmaceutics, 157 (2), 171–179.
   PubMed Web of Science ®Google Scholar
• Shao, J., et al., 2009. Enhanced growth inhibition effect of Resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels. Colloids and surfaces B: Biointerfaces enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels, 72 (1), 40–47.
   Google Scholar
• Singh, S., and Muthu, M.S., 2007. Preparation and characterization of nanoparticles containing an atypical antipsychotic agent. Nanomedicine, 2 (2), 233–240.
   PubMed Web of Science ®Google Scholar
• Singh, R.P., and Ramarao, P., 2013. Accumulated polymer degradation products as effector molecules in cytotoxicity of polymeric nanoparticles. Toxicological sciences, 136 (1), 131–143.
   PubMed Web of Science ®Google Scholar
• Singh, D., et al., 2012. Quercetin-Phospholipid complex: an amorphous pharmaceutical system in herbal drug delivery. Current drug discovery technologies, 9 (1), 17–24.
   PubMedGoogle Scholar
• Sjöberg, M., et al., 1999. The effect of polymer and surfactant adsorption on the colloidal stability and rheology of kaolin dispersions. Colloids and surfaces A: physicochemical and engineering aspects,159, 197–208.
   Web of Science ®Google Scholar
• Stark, B., Pabst, G., and Prassl, R., 2010. Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: effects of cryoprotectants on structure. European journal of pharmaceutical sciences, 41 (3-4), 546–555.
   PubMed Web of Science ®Google Scholar
• Sun, L.P., Chen, A.L., Hung, H.C., et al., 2012. Chrysin: a histone deacetylase 8 inhibitor with anticancer activity and a suitable candidate for the standardization of Chinese propolis. Journal of Agricultural and Food Chemistry, 60 (47), 1174–11758.
   Web of Science ®Google Scholar
• Üner, M., 2006. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Die pharmazie - an international journal of pharmaceutical sciences, 61 (5), 375–386.
   Google Scholar
• Vedagiri, S. and Thangarajan, 2016. Mitigating effect of chrysin loaded solid lipid nanoparticles against Amyloid beta25-35 induced oxidative stress in rat hippocampal region: An efficient formulation approach for Alzheimer’s disease, Neuropeptides, 58, 111–125. doi:10.1016/j.npep.2016.03.002.
   PubMed Web of Science ®Google Scholar
• Wang, Q., et al., 2011. Colloids and surfaces B: biointerfaces structural characterization of novel phospholipid lipid nanoparticles for controlled drug delivery. Colloids surfaces B biointerfaces, 84 (2), 406–412.
   PubMed Web of Science ®Google Scholar
• Walle, T., et al., 2001. Disposition and metabolism of the flavonoid chrysin in normal volunteers. British Journal of Clinical Pharmacology, 51 (2), 143–146.
   PubMed Web of Science ®Google Scholar
• Wei, W., et al., 2010. Lipid nanoparticles loaded with 10-hydroxycamptothecin – phospholipid complex developed for the treatment of hepatoma in clinical application. Journal of drug targeting, 18, 557–566.
   PubMed Web of Science ®Google Scholar
• Westesen, K. and Siekmann, B., 1997. Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles, International journal of pharmaceutics 151, 35–45.
   Web of Science ®Google Scholar
• Zhang, L., et al., 2008. The effects of cryoprotectants on the freeze-drying of ibuprofen-loaded solid lipid microparticles (SLM). European journal of pharmaceutics and biopharmaceutics: official journal of arbeitsgemeinschaft fur pharmazeutische verfahrenstechnik e.v, 69 (2), 750–759.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., Huey, S., and Feng, S., 2007. Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. Folate-decorated poly (lactide- co -glycolide) -vitamin E TPGS nanoparticles for targeted drug delivery, 28 (10), 1889–1899.
   Google Scholar
• Zhu, Z.Y., et al., 2016. Inclusion of chrysin in beta-cyclodextrin and its biological activities. Journal of drug delivery science and technology, 31, 176–186.
   Web of Science ®Google Scholar